Desensitization in interferon-β1a allergy: A case report

International Archives of Allergy and Immunology

Volumn 149, Issue 2, 2009, Pages 178-180

  Kalpaklioglu, Ayse Fusun ^a   Baccioglu Kavut, Ayse ^a   Erdemoglu, Ali Kemal ^a  

^a KIRIKKALE UNIVERSITY   (Turkey)

Author keywords

Desensitization; Drug allergy; Interferon

Indexed keywords

ANTIHISTAMINIC AGENT; BETA1A INTERFERON; MELOXICAM; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PREDNISONE; BETA INTERFERON;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CASE REPORT; DESENSITIZATION; DRUG DOSE INCREASE; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; FEMALE; HUMAN; MAINTENANCE DRUG DOSE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PRURITUS; SKIN TEST; TREATMENT OUTCOME; URTICARIA; IMMUNOLOGY;

ADULT; ANGIOEDEMA; DESENSITIZATION, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; INTERFERON-BETA; MULTIPLE SCLEROSIS; URTICARIA;

EID: 58149155990     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000189203     Document Type: Article

References (12)

1. Yong VW, Chabot S, Stuve O, Williams G: Interferon beta in the treatment of multiple sclerosis: mechanisms of action. Neurology 1998; 51: 682-689.
2. Walther EU, Hohlfeld R: Multiple sclerosis: side effects of interferon beta therapy and their management. Neurology 1999; 53: 1622-1627.
3. Munschauer FE 3rd, Kinkel RP: Managing side effects of interferon-beta in patients with relapsing-remitting multiple sclerosis. Clin Ther 1997; 19: 883-893.
4. Garcia-F-Villalta M, Daudén E, Sánchez J, Fraga J, Ramo C, García-Díez A: Local reactions associated with subcutaneous injections of both beta-interferon 1a and 1b. Acta Derm Venereol 2001; 81:152.
5. Mazzeo L, Ricciardi L, Fazio MC, Fogliani O, Fedele R, Ferlazzo E , Isola S: Severe urticaria due to recombinant interferon beta-1a. Br J Dermatol 2003; 148:171-192.
6. Corona T, Leon C, Ostrosky-Zeicher L: Severe anaphylaxis with recombinant interfer-on beta. Neurology 1999; 52:425.
7. Brown DL, Login IS, Borish L, Powers PL: An urticarial IgE mediated reaction to interfer-on beta-1b. Neurology 2001; 56:1416-1417.
8. Ohmoto K, Yamamoto S: Angioedema after interferon therapy for chronic hepatitis C. Am J Gastroenterol 2001; 96:1311-1312.
9. Arnason BGW, Reder TR: Interferons and multiple sclerosis. Clin Neuropharmacol 1994; 17:495-547.
10. Noronha A, Toscas A, Jensen MA: Interferon beta decreases T cell activation and interfer-on gamma production in multiple sclerosis. J Neuroimmunol 1993; 46: 145-153.
11. Pichler WJ, Campi P: Adverse side effects to biological agents; in Pichler WJ (ed): Drug Hypersensitivity. Basel, Karger, 2007, pp 151-165.
12. Cohen BA, Greenberger PA, Saini S: Delayed occurrence of a severe cutaneous reaction in a multiple sclerosis patient taking interferon beta-1b. Allergy Asthma Proc 1998; 19:85-88.